Mirum Pharmaceuticals Inc (MIRM)
39.26
-0.35
(-0.88%)
USD |
NASDAQ |
Oct 04, 16:00
39.22
-0.04
(-0.10%)
After-Hours: 20:00
Mirum Pharmaceuticals Shareholders Equity (Annual): 248.67M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 248.67M |
| December 31, 2022 | 142.04M |
| December 31, 2021 | 120.21M |
| Date | Value |
|---|---|
| December 31, 2020 | 172.10M |
| December 31, 2019 | 130.35M |
| December 31, 2018 | -10.32M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
120.21M
Minimum
2021
248.67M
Maximum
2023
162.67M
Average
142.04M
Median
2022
Shareholders Equity (Annual) Benchmarks
| TG Therapeutics Inc | 160.50M |
| MannKind Corp | -246.17M |
| Anavex Life Sciences Corp | 141.85M |
| Rhythm Pharmaceuticals Inc | 169.76M |
| Arcutis Biotherapeutics Inc | 88.67M |